Cancer: Still a contraindication for allergen immunotherapy?

Allergen immunotherapy (AIT) is currently more than 100 years old. It is considered an evidence-based efficacious immune therapeutical treatment. It is at this time the only causative treatment for allergic respiratory and venom allergic diseases. Though clinical indications for AIT are well establi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	David El-Qutob, Antonio Letrán, Victor Matheu, Enrique Fernandez-Caldas
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Cancer Neoplasm Specific immunotherapy Allergen Contraindication Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/cedaf78fa050492388dff86f0bcd21ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cedaf78fa050492388dff86f0bcd21ac
record_format	dspace
spelling	oai:doaj.org-article:cedaf78fa050492388dff86f0bcd21ac2021-11-12T04:30:21ZCancer: Still a contraindication for allergen immunotherapy?1939-455110.1016/j.waojou.2021.100597https://doaj.org/article/cedaf78fa050492388dff86f0bcd21ac2021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1939455121000910https://doaj.org/toc/1939-4551Allergen immunotherapy (AIT) is currently more than 100 years old. It is considered an evidence-based efficacious immune therapeutical treatment. It is at this time the only causative treatment for allergic respiratory and venom allergic diseases. Though clinical indications for AIT are well established, clinical contraindications to AIT differ among several guidelines. Regarding malignant neoplasia, traditionally, it has been considered as a relative or absolute contraindication with the concern that AIT might stimulate tumour growth even though pathogenic impact of AIT in cancer is not well understood. Furthermore, this contraindication is often based on observational case series, or case reports, with little real evidence-based data. Therefore, should cancer still be contemplated as an absolute contraindication for AIT?David El-QutobAntonio LetránVictor MatheuEnrique Fernandez-CaldasElsevierarticleCancerNeoplasmSpecific immunotherapyAllergenContraindicationImmunologic diseases. AllergyRC581-607ENWorld Allergy Organization Journal, Vol 14, Iss 10, Pp 100597- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Cancer Neoplasm Specific immunotherapy Allergen Contraindication Immunologic diseases. Allergy RC581-607
spellingShingle	Cancer Neoplasm Specific immunotherapy Allergen Contraindication Immunologic diseases. Allergy RC581-607 David El-Qutob Antonio Letrán Victor Matheu Enrique Fernandez-Caldas Cancer: Still a contraindication for allergen immunotherapy?
description	Allergen immunotherapy (AIT) is currently more than 100 years old. It is considered an evidence-based efficacious immune therapeutical treatment. It is at this time the only causative treatment for allergic respiratory and venom allergic diseases. Though clinical indications for AIT are well established, clinical contraindications to AIT differ among several guidelines. Regarding malignant neoplasia, traditionally, it has been considered as a relative or absolute contraindication with the concern that AIT might stimulate tumour growth even though pathogenic impact of AIT in cancer is not well understood. Furthermore, this contraindication is often based on observational case series, or case reports, with little real evidence-based data. Therefore, should cancer still be contemplated as an absolute contraindication for AIT?
format	article
author	David El-Qutob Antonio Letrán Victor Matheu Enrique Fernandez-Caldas
author_facet	David El-Qutob Antonio Letrán Victor Matheu Enrique Fernandez-Caldas
author_sort	David El-Qutob
title	Cancer: Still a contraindication for allergen immunotherapy?
title_short	Cancer: Still a contraindication for allergen immunotherapy?
title_full	Cancer: Still a contraindication for allergen immunotherapy?
title_fullStr	Cancer: Still a contraindication for allergen immunotherapy?
title_full_unstemmed	Cancer: Still a contraindication for allergen immunotherapy?
title_sort	cancer: still a contraindication for allergen immunotherapy?
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/cedaf78fa050492388dff86f0bcd21ac
work_keys_str_mv	AT davidelqutob cancerstillacontraindicationforallergenimmunotherapy AT antonioletran cancerstillacontraindicationforallergenimmunotherapy AT victormatheu cancerstillacontraindicationforallergenimmunotherapy AT enriquefernandezcaldas cancerstillacontraindicationforallergenimmunotherapy
_version_	1718431317468643328

Cancer: Still a contraindication for allergen immunotherapy?

Ejemplares similares